Approach to the Patient: Hereditary Medullary Thyroid Carcinoma
Omair A. Shariq(Mayo Clinic in Arizona), Nancy D. Perrier(The University of Texas MD Anderson Cancer Center), Sarah Hamidi(The University of Texas MD Anderson Cancer Center), Mimi I. Hu(The University of Texas MD Anderson Cancer Center), Benjamin C Kensing(The University of Texas MD Anderson Cancer Center), Catherine M Skefos(The University of Texas MD Anderson Cancer Center), Steven G. Waguespack(The University of Texas MD Anderson Cancer Center)
Cited by 3
Related Papers
Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven Cancers
|Cancer Discovery|2018|392
American Association of Endocrine Surgeons Guidelines for Adrenalectomy
|JAMA Surgery|2022|224
Thyroid Carcinoma
|Journal of the National Comprehensive Cancer Network|2010|205
Thyroid Carcinoma, Version 2.2014
|Journal of the National Comprehensive Cancer Network|2014|200
Denosumab for Treatment of Hypercalcemia of Malignancy
|The Journal of Clinical Endocrinology & Metabolism|2014|200